Visual Abstract

Introduction: A critical point for using blood purification during sepsis may be the potential interaction with antimicrobial therapy, the mainstay of sepsis treatment. The aim of our study was to investigate the vancomycin removal during hemoperfusion (HP) using HA380 cartridge. Methods: This is an experimental study, in which 500 mL of solution was circulated in a closed-circuit (blood flow of 250 mL/min) simulating HP ran using HA380. Vancomycin was added to reach a through concentration or a very high concentration to evaluate the removal ratio (RR) during 120 min of HP. Comparison between blood-crystalloid solution and balanced solution was performed by using Kruskal-Wallis test. The kinetics of vancomycin removal and the adsorption isotherm were evaluated. Results: We found a complete removal of vancomycin at baseline through concentration of 23.0 ± 7.4 mg/L. Using extremely high concentration (baseline 777.0 ± 62.2 mg/L), RR was 90.1 ± 0.6% at 5 min and 99.2 ± 0.6% at 120 min. No difference in terms of RR was found between blood-crystalloid mixture and balanced solution. The kinetics of the vancomycin reduction followed an exponential decay. Repeated boluses (total amount of 2,000 mg) resulted in cumulative adsorption of 1,919.4 mg with RR of 96.6 ± 1.4%, regardless of the amount injected (100 vs. 500 mg). Vancomycin adsorption onto HA380 followed the Langmuir isotherm model. Conclusions: A considerable amount of vancomycin was rapidly removed during in vitro HP with HA380. Clinical studies are needed to determine whether this may lead to underdosing. Drug therapeutic monitoring is highly recommended when using HA380 for blood purification in patients receiving vancomycin.

1.
Singer
M
,
Deutschman
CS
,
Seymour
CW
,
Shankar-Hari
M
,
Annane
D
,
Bauer
M
, et al
The third international consensus definitions for sepsis and septic shock (Sepsis-3)
.
JAMA
.
2016 Feb 23
;
315
(
8
):
801
10
. .
2.
Ankawi
G
,
Neri
M
,
Zhang
J
,
Breglia
A
,
Ricci
Z
,
Ronco
C
.
Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls
.
Crit Care
.
2018
;
22
(
1
):
262
. .
3.
Huang
Z
,
Wang
SR
,
Su
W
,
Liu
JY
.
Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column
.
Ther Apher Dial
.
2010 Dec
;
14
(
6
):
596
602
. .
4.
Huang
Z
,
Wang
SR
,
Yang
ZL
,
Liu
JY
.
Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column
.
Ther Apher Dial
.
2013 Aug
;
17
(
4
):
454
61
. .
5.
Rhodes
A
,
Evans
LE
,
Alhazzani
W
,
Levy
MM
,
Antonelli
M
,
Ferrer
R
, et al
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock
.
Intensive Care Med
.
20162017 Mar
;
43
(
3
):
304
77
.
6.
Martinez
MN
,
Papich
MG
,
Drusano
GL
.
Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target
.
Antimicrob Agents Chemother
.
2012 Jun
;
56
(
6
):
2795
805
. .
7.
Blot
S
,
Koulenti
D
,
Akova
M
,
Bassetti
M
,
De Waele
JJ
,
Dimopoulos
G
, et al
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
.
Crit Care
.
2014 May 15
;
18
(
3
):
R99
. .
8.
Haddadin
AS
,
Fappiano
SA
,
Lipsett
PA
.
Methicillin resistant taphylococcus aureus (MRSA) in the intensive care unit
.
Postgrad Med J
.
2002 Jul
;
78
(
921
):
385
92
. .
9.
Men
P
,
Li
HB
,
Zhai
SD
,
Zhao
RS
.
Association between the AUC0-24/MIC Ratio of vancomycin and its clinical effectiveness: a systematic review and meta-analysis
.
PLoS One
.
2016 Jan 5
;
11
(
1
):
e0146224
. .
10.
Huang
C
,
Wang
Y
,
Li
X
,
Ren
L
,
Zhao
J
,
Hu
Y
, et al
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
.
Lancet
.
2020 Feb 15
;
395
(
10223
):
497
506
.
11.
Ronco
C
,
Navalesi
P
,
Vincent
JL
.
Coronavirus epidemic: preparing for extracorporeal organ support in intensive care
.
Lancet Respir Med
.
2020 Mar
;
8
(
3
):
240
1
. .
12.
Uyeki
TM
,
Bernstein
HH
,
Bradley
JS
,
Englund
JA
,
File
TM
,
Fry
AM
, et al
Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa
.
Clin Infect Dis
.
2019 Mar 5
;
68
(
6
):
895
902
.
13.
Patiha
EH
,
Heraldy
E
,
Hidayat
Y
,
Firdaus
M
.
The langmuir isotherm adsorption equation: the monolayer approach
.
IOP Conf Ser: Mater Sci Eng
.
2016 Feb
;
107
(
1
):
012067
. .
14.
Corwin
HL
,
Gettinger
A
,
Rodriguez
RM
,
Pearl
RG
,
Gubler
KD
,
Enny
C
, et al
Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial
.
Crit Care Med
.
2006 Sep
;
34
(
9
):
2310
6
.
15.
Chen
J
,
Han
W
,
Chen
J
,
Zong
W
,
Wang
W
,
Wang
Y
, et al
High performance of a unique mesoporous polystyrene-based adsorbent for blood purification
.
Regen Biomater
.
2017 Feb
;
4
(
1
):
31
7
. .
16.
Xu
X
,
Jia
C
,
Luo
S
,
Li
Y
,
Xiao
F
,
Dai
H
, et al
Effect of HA330 resin-directed hemoadsorption on a porcine acute respiratory distress syndrome model
.
Ann Intensive Care
.
2017 Aug 14
;
7
(
1
):
84
. .
17.
Pomare Montin
D
,
Ankawi
G
,
Lorenzin
A
,
Neri
M
,
Caprara
C
,
Ronco
C
.
Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion
.
Blood Purif
.
2018
;
46
(
3
):
187
95
.
18.
Lorenzin
A
,
Neri
M
,
de Cal
M
,
Pajarin
G
,
Mansi Montenegro
G
,
Savastano
S
, et al
Fluid dynamics analysis by CT imaging technique of new sorbent cartridges for extracorporeal therapies
.
Blood Purif
.
2019
;
48
(
1
):
18
24
. .
19.
Reiter
K
,
Bordoni
V
,
Dall’Olio
G
,
Ricatti
MG
,
Soli
M
,
Ruperti
S
, et al
In vitro removal of therapeutic drugs with a novel adsorbent system
.
Blood Purif
.
2002
;
20
(
4
):
380
8
. .
20.
Sartori
M
,
Day
S
,
De Rosa
S
,
Ricatti
MG
,
Nalesso
F
,
Zancato
M
, et al
Pharmacokinetic analysis of antibiotic adsorption (vancomycin and teicoplanin) by the lixelle extracorporeal unit
.
Int J Artif Organs
.
2015 Jan
;
38
(
1
):
8
12
. .
21.
Konig
C
,
Rohr
AC
,
Frey
OR
,
Brinkmann
A
,
Roberts
JA
,
Wichmann
D
, et al
In vitro removal of anti-infective agents by a novel cytokine adsorbent system
.
Int J Artif Organs
.
2019 Feb
;
42
(
2
):
57
64
.
22.
Clark
WR
,
Gao
D
,
Lorenzin
A
,
Ronco
C
.
Membranes and sorbents
.
Contrib Nephrol
.
2018
;
194
:
70
9
. .
23.
Roberts
JA
,
Taccone
FS
,
Udy
AA
,
Vincent
JL
,
Jacobs
F
,
Lipman
J
.
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens
.
Antimicrob Agents Chemother
.
2011 Jun
;
55
(
6
):
2704
9
. .
24.
Hanaor
DA
,
Ghadiri
M
,
Chrzanowski
W
,
Gan
Y
.
Scalable surface area characterization by electrokinetic analysis of complex anion adsorption
.
Langmuir
.
2014 Dec 23
;
30
(
50
):
15143
52
. .
25.
Rybak
MJ
,
Lomaestro
BM
,
Rotschafer
JC
,
Moellering
RC
,
Craig
WA
,
Billeter
M
, et al
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases society of America, the American society of health-system pharmacists, and the society of infectious diseases pharmacists
.
Clin Infect Dis
.
2009 Aug 1
;
49
(
3
):
325
7
. .
26.
Flannery
AH
,
Bissell
BD
,
Bastin
MT
,
Morris
PE
,
Neyra
JA
.
Continuous versus intermittent infusion of vancomycin and the risk of acute kidney injury in critically ill adults: a systematic review and meta-analysis
.
Crit Care Med
.
2020 Jun
;
48
(
6
):
912
8
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.